2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Michael Friedlander, MD. PhD

Professor
Prince of Wales Cancer Centre
Prince of Wales Cancer Centre
High Street
Randwick, Sydney Australia 2031

Papers:
13 Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for post-progression PARP inhibitor therapy